FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2151642789> ?p ?o ?g. }

• W2151642789 abstract "Several questionnaires have been used to measure health related quality of life (HRQoL) in patients with psoriasis, few have been adapted for use in Spain; none of them was developed specifically for the Spanish population. The purpose of the study was to validate and assess the sensitivity to change of a new questionnaire to measure HRQOL in patients with psoriasis (PSO-LIFE).Observational, prospective, multicenter study performed in centers around Spain. Patients with active or inactive psoriasis completed the PSO-LIFE together with other Dermatology Quality of Life Index (DLQI) and Psoriasis Disability Index (PDI). A control group of patients with urticaria or atopic dermatitis was also included. Internal consistency and test-retest reliability of the PSO-LIFE were assessed by calculating Cronbach's alpha and Intraclass Correlation Coefficient (ICC). Validity was assessed by examining factorial structure, the capacity to discriminate between groups, and correlations with other measures. Sensitivity to change was measured using effect sizes.The final sample included for analysis consisted of 304 patients and 56 controls. Mean (SD) age of psoriasis patients was 45.3 (14.5) years compared to 38.8 (14) years for controls (p < 0.01). Cronbach's alpha for the PSO-LIFE was 0.95 and test-retest reliability using the ICC was 0.98. Factor analysis showed the questionnaire to be unidimensional. Mean (SD) PSO-LIFE scores differed between patients with psoriasis and controls (64.9 [22.5] vs 69.4 [17.3]; p < 0.05), between those with active and inactive disease (57.4 [20.4] vs 76.4 [20.6]; p < 0.01), and between those with visible and non-visible lesions (63.0 [21.9] vs. 74.8 [23.9]; p < 0.01). The correlation between PSO-LIFE and PASI scores was moderate (r = -0.43) while correlations with DLQI and PDI dimensions ranged from moderate to high (between 0.4 and 0.8). Effect size on the PSO-LIFE in patients reporting 'much improved' health status at study completion was 1.01 (large effect size).The present results provide substantial support for the reliability, validity, and responsiveness of the PSO-LIFE questionnaire in the population for which it was designed." @default.
• W2151642789 created "2016-06-24" @default.
• W2151642789 creator A5016602932 @default.
• W2151642789 creator A5027590834 @default.
• W2151642789 creator A5030191850 @default.
• W2151642789 creator A5030936251 @default.
• W2151642789 creator A5034720013 @default.
• W2151642789 creator A5035372676 @default.
• W2151642789 creator A5052436664 @default.
• W2151642789 creator A5063857408 @default.
• W2151642789 creator A5076998588 @default.
• W2151642789 date "2012-05-24" @default.
• W2151642789 modified "2023-10-09" @default.
• W2151642789 title "Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire" @default.
• W2151642789 cites W1583848026 @default.
• W2151642789 cites W1953250907 @default.
• W2151642789 cites W1971641451 @default.
• W2151642789 cites W1973487894 @default.
• W2151642789 cites W1986676847 @default.
• W2151642789 cites W1992296675 @default.
• W2151642789 cites W1995509648 @default.
• W2151642789 cites W2008369163 @default.
• W2151642789 cites W2043469120 @default.
• W2151642789 cites W2044748379 @default.
• W2151642789 cites W2048237668 @default.
• W2151642789 cites W2049817038 @default.
• W2151642789 cites W2095297002 @default.
• W2151642789 cites W2105318078 @default.
• W2151642789 cites W2106146462 @default.
• W2151642789 cites W2132422603 @default.
• W2151642789 cites W2134206785 @default.
• W2151642789 cites W2145628010 @default.
• W2151642789 cites W2170384517 @default.
• W2151642789 cites W2401460160 @default.
• W2151642789 cites W4234328512 @default.
• W2151642789 cites W4245157584 @default.
• W2151642789 cites W4376595371 @default.
• W2151642789 doi "https://doi.org/10.1186/1477-7525-10-56" @default.
• W2151642789 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3458920" @default.
• W2151642789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22624984" @default.
• W2151642789 hasPublicationYear "2012" @default.
• W2151642789 type Work @default.
• W2151642789 sameAs 2151642789 @default.
• W2151642789 citedByCount "17" @default.
• W2151642789 countsByYear W21516427892013 @default.
• W2151642789 countsByYear W21516427892014 @default.
• W2151642789 countsByYear W21516427892015 @default.
• W2151642789 countsByYear W21516427892016 @default.
• W2151642789 countsByYear W21516427892017 @default.
• W2151642789 countsByYear W21516427892018 @default.
• W2151642789 countsByYear W21516427892019 @default.
• W2151642789 countsByYear W21516427892020 @default.
• W2151642789 countsByYear W21516427892021 @default.
• W2151642789 countsByYear W21516427892022 @default.
• W2151642789 crossrefType "journal-article" @default.
• W2151642789 hasAuthorship W2151642789A5016602932 @default.
• W2151642789 hasAuthorship W2151642789A5027590834 @default.
• W2151642789 hasAuthorship W2151642789A5030191850 @default.
• W2151642789 hasAuthorship W2151642789A5030936251 @default.
• W2151642789 hasAuthorship W2151642789A5034720013 @default.
• W2151642789 hasAuthorship W2151642789A5035372676 @default.
• W2151642789 hasAuthorship W2151642789A5052436664 @default.
• W2151642789 hasAuthorship W2151642789A5063857408 @default.
• W2151642789 hasAuthorship W2151642789A5076998588 @default.
• W2151642789 hasBestOaLocation W21516427891 @default.
• W2151642789 hasConcept C104709138 @default.
• W2151642789 hasConcept C106906290 @default.
• W2151642789 hasConcept C126322002 @default.
• W2151642789 hasConcept C159110408 @default.
• W2151642789 hasConcept C16005928 @default.
• W2151642789 hasConcept C171606756 @default.
• W2151642789 hasConcept C1862650 @default.
• W2151642789 hasConcept C23131810 @default.
• W2151642789 hasConcept C2776173921 @default.
• W2151642789 hasConcept C2779951463 @default.
• W2151642789 hasConcept C2780564577 @default.
• W2151642789 hasConcept C2908647359 @default.
• W2151642789 hasConcept C30036603 @default.
• W2151642789 hasConcept C70410870 @default.
• W2151642789 hasConcept C71924100 @default.
• W2151642789 hasConcept C99454951 @default.
• W2151642789 hasConceptScore W2151642789C104709138 @default.
• W2151642789 hasConceptScore W2151642789C106906290 @default.
• W2151642789 hasConceptScore W2151642789C126322002 @default.
• W2151642789 hasConceptScore W2151642789C159110408 @default.
• W2151642789 hasConceptScore W2151642789C16005928 @default.
• W2151642789 hasConceptScore W2151642789C171606756 @default.
• W2151642789 hasConceptScore W2151642789C1862650 @default.
• W2151642789 hasConceptScore W2151642789C23131810 @default.
• W2151642789 hasConceptScore W2151642789C2776173921 @default.
• W2151642789 hasConceptScore W2151642789C2779951463 @default.
• W2151642789 hasConceptScore W2151642789C2780564577 @default.
• W2151642789 hasConceptScore W2151642789C2908647359 @default.
• W2151642789 hasConceptScore W2151642789C30036603 @default.
• W2151642789 hasConceptScore W2151642789C70410870 @default.
• W2151642789 hasConceptScore W2151642789C71924100 @default.
• W2151642789 hasConceptScore W2151642789C99454951 @default.
• W2151642789 hasIssue "1" @default.
• W2151642789 hasLocation W21516427891 @default.
• W2151642789 hasLocation W21516427892 @default.

• next